Medovate, a medical device development company, has announced that the SAFIRA (SAFer Injection for Regional Anesthesia) Palm Operator has officially been launched in the Singapore market having successfully secured approval from the Singapore HSA.
Medovate and its Saudi Arabia based distributor AKSIA Healthcare have announced they have secured SFDA (Saudi Food and Drug Authority) Approval for the SAFIRA (SAFer Injection for Regional Anaesthesia) technology.
UK-based Medovate has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIR (SAFer Injection for Regional Anesthesia) product range in Saudi Arabia, the UAE and Bahrain.